Schedule 13G ownership disclosure

GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK

Common Stock · CUSIP: 36266G107

Event date: 2025-05-30

Filing-level shares
21,960,815.00
Percent of class
4.8%
  • Capital Research Global Investors

    Shares: 21,960,815.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-25-000134
Form type
SCHEDULE 13G/A
Filer
Capital Research Global Investors
CIK
CIK 1422848
Filed
Jun 06, 2025
Reporting period
May 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub